Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
https://www.greenbox.co.uk/collections/cbd-products/cbd-oil/
On March 8 2021 growing on 5 acres was 15000 grams of oil per day pans out at $1 . 2 million per day.......
APOL shares no longer being sold by Barclays
Stephen D. Barnhill, M.D. CEO of Apollon, commented , "We are delighted to welcome Rod to the Board as a Non-Executive Director. Rod, a significant shareholder in the Company, has a long-established career with a demonstrable record of growing small cap companies and creating shareholder value of many business ventures over a long career. He brings a wealth of financial and directorial experience to the team, and I look forward to working with him as we move our business towards the global rollout of Apollon's product range and medical expertise to supportive jurisdictions."
Rod McIllree, Non-Executive Director, stated, "Apollon is an excellent example of utilising research and development to help improve people's lives. The compelling results of Apollon's formulations killing cancer cells in 3D-cell culture and the upcoming opening of the International Cancer and Chronic Pain Institute in Jamaica are important milestones for the Company and offers outstanding potential on many fronts. I look forward to working with Dr Barnhill and the wider Apollon team at this exciting time for growth as the Company looks to execute on the various business partnership opportunities becoming available."
https://www.investegate.co.uk/apollon-formularies/apol/appointment-of-non-executive-director/202201120700051378Y/?fe=1&utm_source=FE%20Investegate%20Alerts&utm_medium=Email&utm_content=Announcement%20Alert%20Mail&utm_campaign=Apollon+Formularies%20Alert
This will hopefully raise a bit of interest here.
Does anyone here know the likely.export.value?
"20 litres of full spectrum medical cannabis oil per day'
Advancing without huge cash burn..........................
https://finance.yahoo.com/news/apollon-formularies-enters-agreements-cla-103100069.html
On the cards since 2019.................
“Let me also congratulate Apollon on its Extraction Laboratory, which is now completed and ready to produce world-class medically certified oils and cannabis extracts. Indeed, Apollon is set to help Jamaica achieve its rightful place in the global sphere for medicinal cannabis products and services,” Mr. Green said.
He further hailed the community-based initiative, Apollon Kannabiz Collective, through which traditional ganja farmers are able to move into the legal industry.
“Apollon is, indeed, cognisant of the need to develop a holistic sector, which does not overlook the traditional farmers. Indeed, let us allow our farmers to not just grow for the sector but to also grow with the sector in a meaningful and sustainable way,” Mr. Green noted.
https://jis.gov.jm/cannabis-can-provide-big-boost-for-tourism/
Wonder how many acres............
Blytheweigh
@Blytheweigh
·
14m
(3/3) Apollon has also established the Apollon Kannabiz Cooperative, working with local farmers to help ensure that these traditional growers are not excluded from the regulated medical cannabis system
Show this thread
Blytheweigh
@Blytheweigh
·
25m
(2/3) This increase in stock levels will allow #APOL to accelerate the processing and manufacturing of #medicalcannabis products for patients, clinical trials, and export to jurisdictions where import is legal
#Health #Apollon #Cancer
Show this thread
Blytheweigh
@Blytheweigh
·
41m
(1/3) ??
@apollon_uk
has signed more than a dozen Tripartite Agreements with
@cla_jamaica
licensed cultivators, providing Apollon with consistent access to large quantities of high-quality #cannabis buds to increase its product inventory. Read more here: http://ow.ly/UkXU50HqFVc
In addition, the Company has established the Apollon Kannabiz Cooperative in an effort to ensure that traditional growers are not left out of the regulated medical cannabis system. Apollon believes that the local farmers should not only "grow for us" but should also be given an opportunity to "grow with us".
https://www.lse.co.uk/rns/tripartite-agreements-with-licensed-cultivators-rcvxtzbd7gdtfb2.html
Apollon Formularies inks agreements with 'over a dozen' cannabis growers in Jamaica............
https://www.proactiveinvestors.co.uk/companies/news/970686/apollon-formularies-inks-agreements-with-over-a-dozen-cannabis-growers-in-jamaica-970686.html
Apollon Formularies
@apollon_uk
·
1h
#APOL's goal is to reposition Jamaica's medical cannabis industry, in terms of science, research & development, product manufacturing, affordable patient care, and legal export, while becoming an industry leader in the global pharmaceutical & nutraceutical medical cannabis space
:+)
Very good news this morning, looks like that is the supply side of the equation sorted and with a strong ESG element to boot.
One solid step after another.
Apollon Formularies
@apollon_uk
·
Dec 29, 2021
When appointing a Medical Director of the new Cancer Institute, #Apollon's board were so pleased to be able to fill the position with Dr. Dingle Spence, a licensed Jamaican physician specialising in Clinical Oncology, Radiation Therapy & Palliative Care Medicine
#MedicalCannabis
Apollon Formularies
@apollon_uk
·
Jan 5
(3/3) Apollon is excited by the prospect of seeing European jurisdictions move towards changing legislation on medical cannabis as we recently announced completion of a high-volume processing lab in preparation for global export to those countries where legal import is allowed
06.01.22 | 15:07:05 20000 2.5
https://www.aquis.eu/aquis-stock-exchange/member?securityidaqse=APOL
Apollon's Processing (Tier 1) License allows the Company to operate its newly completed state-of-the-art medical cannabis pharmaceutical processing laboratory. This upgraded facility has the capacity to produce approximately 20 litres of full spectrum medical cannabis oil per day, allowing Apollon to significantly increase its inventory in preparation for global export to those countries where legal import is allowed, to have sufficient amounts of medical cannabis oil available for potential pharmaceutical partners to perform independent clinical trial validations, and provide medical cannabis products for Apollon to perform clinical trials at the International Cancer and Chronic Pain Institute ("ICCPI") in Kingston, Jamaica.
https://polaris.brighterir.com/public/apollon_formularies/news/rns/story/r7536jw
https://www.investegate.co.uk/apollon-formularies--apol-/rns/approval-of-medical-cannabis-license-renewals/202201061025066523X/
Another box ticked...